Low-concentration bimatoprost 0.01% and timolol 0.1% eye gel versus bimatoprost 0.03% and timolol 0.5% eye drops in open-angle glaucoma or ocular hypertension: a phase III randomised study.

Br J Ophthalmol · 2026 · PMC13018773 · PMID 41093358

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a numerical trendno p-value reported

At week 12, a numerical trend was noted in favour of BTFC eye gel over BTFC eye drops for the investigators (96.0% and 93.2%, respectively) and patients (95.3% and 91.3%, respectively).

also in 691 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.